About 5 results found for searched term "TT-10" (0.051 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M8874 | C188-9 | STAT |
| TTI-101 | ||
| C188-9 is a small-molecule STAT3 inhibitor, can block Th2 and Th17 cell expansion and cytokine production to prevent house dust mite (HDM)-induced airway inflammation and remodeling. | ||
| M24546 | Timolumab | Others |
| BTT 1023; Anti-Human AOC3 Recombinant Antibody | ||
| Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases. | ||
| M24976 | Astegolimab | IL Receptor/Related |
| MSTT 1041A; RG 6149 | ||
| Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research. | ||
| M29390 | TT-10 | YAP |
| TAZ-K | ||
| TT-10 (TAZ-K) is an activator of YES-associated protein (YAP)-transcriptional enhancer factor domain (TEAD) activity. TT-10 can be used for the research of heart diseases accompanied by cardiomyocyte loss. | ||
| M40649 | PORT-6 | Adenosine Receptor |
| TT-10 | ||
| PORT-6 is an adenosine receptor A2aR inhibitor that can be used in a variety of tumor-related studies. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
